Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **voltage-dependent calcium channel α2δ-1 subunit** is an **auxiliary protein** associated with high-voltage–activated (e.g., L-type and N-type) calcium channels in neurons, muscle, and cardiac tissue[1][2][5][7]. It is anchored to the extracellular side of the membrane, increasing calcium current density by promoting trafficking and functional expression of the α1 pore-forming subunits on the plasma membrane and altering channel gating properties[1][3][5]. The α2δ-1 subunit also acts as a receptor for gabapentinoid drugs (gabapentin, pregabalin), which alleviates neuropathic pain by inhibiting pathological channel trafficking and neurotransmitter release[4][7]. Beyond its auxiliary channel functions, α2δ-1 is involved in synaptic organization through interactions with thrombospondins and is implicated in multiple neurological and cardiovascular disorders[6][7].
Gabapentinoids bind to the α2δ-1 subunit, inhibiting trafficking of voltage-gated calcium channels to the membrane, reducing synaptic calcium influx and neurotransmitter release, thus diminishing pain signaling
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel α2δ-1 subunit (α2δ-1).